Discover
SRPT
Sarepta Therapeutics, Inc.
17.91
2 x 17.88
1 x 17.89
bid
ask
+
0.73
4.25%
02:54 PM
timesize
| Ytd | -16.78% | |
| 1y | -0.17% |
17.35
day range
18.02
14.68
52 week range
25.32
| Open | 17.35 | Prev Close | 17.18 | Low | 17.35 | High | 18.02 | Mkt Cap | 1.89B |
| Vol | 1.58M | Avg Vol | 3.39M | EPS | -0.60 | P/E | -29.81 | Forward P/E | 6.46 |
| Beta | 0.23 | Short Ratio | 7.12 | Inst. Own | 107.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 16.89 | 200-d Avg | 19.23 | 1yr Est | 22.09 |
| Income Statement | |||
| Total Revenue | 401.25M | ||
| Revenues (USD) | 401.25M | ||
| Cost of Revenue | 149.39M | ||
| Gross Profit | 251.87M | ||
| Operating Expenses | 238.58M | ||
| Research and Development Expense | 91.26M | ||
| Selling, General and Administrative Expense | 107.60M | ||
| Operating Income | 13.29M | ||
| Income Tax Expense | 3.14M | ||
| Net Income | -4.89M | ||
| Net Income Common Stock | -4.89M | ||
| Net Income Common Stock (USD) | -4.89M | ||
| Consolidated Income | -4.89M | ||
| Earnings per Basic Share | -0.05 | ||
| Earnings per Basic Share (USD) | -0.05 | ||
| Earnings per Diluted Share | -0.05 | ||
| Earning Before Interest & Taxes (EBIT) | -1.75M | ||
| Earning Before Interest & Taxes (USD) | -1.75M | ||
| Weighted Average Shares | 105.43M | ||
| Weighted Average Shares Diluted | 105.43M | ||
| Balance Sheet | |||
| Cash and Equivalents | 571.15M | ||
| Cash and Equivalents (USD) | 571.15M | ||
| Investments | 362.71M | ||
| Investments Current | 217.34M | ||
| Investments Non-Current | 145.37M | ||
| Trade and Non-Trade Receivables | 376.82M | ||
| Current Assets | 2.22B | ||
| Property, Plant & Equipment Net | 446.84M | ||
| Total Assets | 3.19B | ||
| Total Debt | 1.05B | ||
| Current Liabilities | 502.91M | ||
| Debt Non-Current | 1.05B | ||
| Total Liabilities | 1.66B | ||
| Accumulated Retained Earnings (Deficit) | -4.55B | ||
| Accumulated Other Comprehensive Income | -565.00K | ||
| Shareholders Equity | 1.53B | ||
| Shareholders Equity (USD) | 1.53B | ||
| Assets Non-Current | 964.69M | ||
| Total Debt (USD) | 1.05B | ||
| Deferred Revenue | 220.26M | ||
| Inventory | 1.13B | ||
| Liabilities Non-Current | 1.16B | ||
| Trade and Non-Trade Payables | 50.98M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 13.62M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 103.70M | ||
| Capital Expenditure | -555.00K | ||
| Net Cash Flow from Investing | -93.37M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -92.82M | ||
| Net Cash Flow from Operations | 197.07M | ||
| Share Based Compensation | 24.47M | ||